Book Value per Share: zyversa.com (ZVSA)

Graphic logo of ZyVersa Therapeutics, Inc. (ZVSA)

ZyVersa Therapeutics (ZVSA) possesses latent pricing power that will be realized through patents following the completion of clinical trials. The historical book value per share assessment on GURU.Markets reflects the tangible asset base, where the parameter value reaches 3.18. The project relies on a lean team of scientists with RSU-based incentives, yet it faces financial uncertainty and the risk of failure in kidney drug trials.

ZyVersa (ZVSA): Share Book Value from 04/28/2023 to 08/02/2025

ZyVersa Therapeutics Inc. - analytical breakdowns and key metrics (ZVSA)

- price and consensus price forecast:
Price Chart ZyVersa|ZVSA - Analyst Median Target
- market capitalization data:
Market Capitalization ZyVersa Therapeutics, Inc.|ZVSA - Enterprise Value
- book capitalization data:
Net Assets per Single Share ZyVersa Therapeutics|ZVSA - Net Asset Value|Market Capitalization to Book Value Ratio zyversa.com|ZVSA - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital ZyVersa Therapeutics|ZVSA - Long-Term Debt to Capital|Short-Term Debt to Equity ZyVersa|ZVSA - Aggregate Debt Obligations|Debt to Book Capitalization Ratio ZyVersa Therapeutics, Inc.
Fundamental company valuation:zyversa.com - ZVSA
Manufactured products of ZyVersa

For ZyVersa Therapeutics (ZVSA), which focuses on innovative therapies for renal inflammation, the book value per common share dynamics on GURU.Markets reflect the actual value of net assets. This indicator is calculated as the difference between total equity and liabilities divided by the number of shares, allowing the investor to assess the intrinsic value of the business without accounting for market speculation and overvalued expectations.

Competitors of ZyVersa Therapeutics (ZVSA)

Net Assets per Single Share TVTX (Retrophin)|ARDX - Net Assets per Share|PROK: Book Value per Share|AKBA (akebia.com) - Book Value per Share|Net Assets per Single Share Cara Therapeutics TVRD|Share Book Value DiaMedica Therapeutics Inc|Unicycive (UNCY) - Book Value per Share|Accounting Value of a Share Rockwell Medical Inc. (RMTI)|Book Value per Share CVKD (Cadrenal Therapeutics)|conduitpharma.com - Book Value per Share|Net Assets per Single Share Calliditas (CALT)|RNLX: Accounting Value of a Share